Sangree, Annabel K. http://orcid.org/0000-0002-0298-1856
Griffith, Audrey L. http://orcid.org/0000-0001-5552-2939
Szegletes, Zsofia M. http://orcid.org/0000-0003-2494-5642
Roy, Priyanka http://orcid.org/0000-0003-2934-538X
DeWeirdt, Peter C.
Hegde, Mudra http://orcid.org/0000-0003-4530-4633
McGee, Abby V. http://orcid.org/0000-0001-9294-7039
Hanna, Ruth E.
Doench, John G. http://orcid.org/0000-0002-3707-9889
Article History
Received: 8 July 2021
Accepted: 18 February 2022
First Online: 14 March 2022
Competing interests
: JGD consults for Microsoft Research, Agios, Phenomic AI, Maze Therapeutics, BioNTech, and Pfizer; JGD consults for and has equity in Tango Therapeutics. JGD’s research is supported in part by the Functional Genomics Consortium (Merck, Abbvie, Janssen, Vir, and Bristol Meyers Squibb). JGD’s interests were reviewed and are managed by the Broad Institute in accordance with its conflict of interest policies. All other authors declare no competing interests.